← Leaderboards
Ira Jay Goldberg
New York University School Of Medicine
$42,989,404
Attributed
$48,895,466
Total exposure
21
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,895,466 · 21
By mechanism
R01$26,237,634 · 8
P01$9,516,739 · 6
T32$5,279,220 · 2
R37$4,554,956 · 1
U01$2,012,162 · 1
P50$864,355 · 2
Top collaborators
- Glenn I Fishman7 shared
- Edward A Fisher6 shared
- Nada A. Abumrad4 shared
- Ravichandran Ramasamy4 shared
- Li Shin Huang2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Seth J. Orlow$11,704,418
Others in their field
Top investigators on “Lipoprotein Lipase”
- Stephen G Young · J. David Gladstone Institutes$23,639,489
- Daniel James Rader · University Of Pennsylvania$13,381,458
- William S Blaner · Columbia University Health Sciences$6,260,923
- Thomas S. Kupper · Dana-Farber Cancer Institute$5,975,062
- Robert H Eckel · University Of Colorado Denver$5,911,430
- Frederick R. Maxfield · Weill Medical College Of Cornell Univ$5,898,549
Research focus
Lipoprotein LipaseLipidsAffectLipoproteinsPathway InteractionsCellsTriglyceridesLipolysisPreventCholesterolUptakeDiabetes MellitusGene ExpressionGlucoseMediatingAtherosclerosisMacrophageEndothelial CellsIn VivoTissuesKnockout MiceHeartKnock-OutGenes
Grant awards (105)
Cholesterol reduction and cardiovascular risk in Type 1 diabetes$844,283
R01 · FY2025 · HL · contact PI
Chylomicrons and endothelial biology$827,884
R01 · FY2025 · HL · contact PI
Project 3: Triglycerides, lipolysis, and vascular inflammation$633,102
P01 · FY2025 · HL · contact PI
Training Program in Cardiometabolic Diseases$606,454
T32 · FY2025 · HL
Blood TG clearance and vascular biology$566,758
P01 · FY2025 · HL · contact PI
Cholesterol reduction and cardiovascular risk in Type 1 diabetes$844,212
R01 · FY2024 · HL · contact PI
Chylomicrons and endothelial biology$811,326
R01 · FY2024 · HL · contact PI
Pathways of Tissue Lipid Uptake$753,659
R01 · FY2024 · HL · contact PI
Blood TG clearance and vascular biology$647,320
P01 · FY2024 · HL · contact PI
Project 3: Lipolysis regulation and diabetes-impaired regression$487,028
P01 · FY2024 · HL · contact PI
Training Program in Cardiometabolic Diseases$330,925
T32 · FY2024 · HL
Cholesterol reduction and cardiovascular risk in Type 1 diabetes$844,142
R01 · FY2023 · HL · contact PI
Chylomicrons and endothelial biology$827,884
R01 · FY2023 · HL · contact PI
Pathways of Tissue Lipid Uptake$770,444
R01 · FY2023 · HL · contact PI
Blood TG clearance and vascular biology$634,166
P01 · FY2023 · HL · contact PI
Training Program in Cardiometabolic Diseases$564,371
T32 · FY2023 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression$496,387
P01 · FY2023 · HL · contact PI
Cholesterol reduction and cardiovascular risk in Type 1 diabetes$861,449
R01 · FY2022 · HL · contact PI
Pathways of Tissue Lipid Uptake$771,719
R01 · FY2022 · HL · contact PI
Training Program in Cardiometabolic Diseases$550,698
T32 · FY2022 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression$493,885
P01 · FY2022 · HL · contact PI
Pathways of Tissue Lipid Uptake$764,581
R01 · FY2021 · HL · contact PI
Mechanisms of Fatty Acid Uptake by Cardiac Muscle$542,000
R01 · FY2021 · HL · contact PI
Training Program in Cardiometabolic Diseases$527,170
T32 · FY2021 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression$493,774
P01 · FY2021 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2020 · HL · contact PI
Mechanisms of Fatty Acid Uptake by Cardiac Muscle$542,000
R01 · FY2020 · HL · contact PI
Training Program in Cardiometabolic Diseases$519,446
T32 · FY2020 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression$505,193
P01 · FY2020 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2019 · HL · contact PI
Mechanisms of Fatty Acid Uptake by Cardiac Muscle$542,000
R01 · FY2019 · HL · contact PI
Project 2: Dyslipidemia and Atherosclerosis Regression$455,599
P01 · FY2019 · HL · contact PI
Training Program in Cardiovascular Sciences$177,352
T32 · FY2019 · HL
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2018 · HL · contact PI
Mechanisms of Fatty Acid Uptake by Cardiac Muscle$542,000
R01 · FY2018 · HL · contact PI
Extracellular regulation of lipoprotein lipase activity$481,144
R01 · FY2018 · HL · contact PI
Project 2: Dyslipidemia and Atherosclerosis Regression$465,566
P01 · FY2018 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2017 · HL · contact PI
Extracellular regulation of lipoprotein lipase activity$481,144
R01 · FY2017 · HL · contact PI
Project 2: Dyslipidemia and Atherosclerosis Regression$465,566
P01 · FY2017 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$558,164
R01 · FY2016 · DK
Extracellular regulation of lipoprotein lipase activity$482,118
R01 · FY2016 · HL · contact PI
Project 2: Dyslipidemia and Atherosclerosis Regression$449,355
P01 · FY2016 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$617,182
R01 · FY2015 · DK
Extracellular regulation of lipoprotein lipase activity$497,545
R01 · FY2015 · HL · contact PI
Project 2: Dyslipidemia and Atherosclerosis Regression$467,855
P01 · FY2015 · HL · contact PI
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$465,355
R01 · FY2015 · HL · contact PI
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$470,161
R01 · FY2014 · HL · contact PI
Diabetes-Mediated Effects on Myeloid Precursors and Vascular Complications$345,885
R01 · FY2014 · DK
Diabetes-mediated effects on myeloid precursors and vascular complications$59,018
R01 · FY2014 · DK
Diabetes-mediated effects on myeloid precursors and vascular complications$525,085
R01 · FY2013 · DK
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$419,421
R01 · FY2013 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$361,749
R01 · FY2013 · HL · contact PI
Nutritional and Hormonal Pathways for Reduction of ApoB-lipoproteins$190,400
R21 · FY2013 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$84,380
R01 · FY2013 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$561,379
R01 · FY2012 · DK
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$468,623
R01 · FY2012 · HL · contact PI
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$440,570
R01 · FY2012 · HL · contact PI
Postdoctoral Training in Arteriosclerosis Research$343,420
T32 · FY2012 · HL · contact PI
Nutritional and Hormonal Pathways for Reduction of ApoB-lipoproteins$240,000
R21 · FY2012 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$468,623
R01 · FY2011 · HL · contact PI
Postdoctoral Training in Arteriosclerosis Research$236,026
T32 · FY2011 · HL · contact PI
Hyperglycemia, Aldose Reductase and Murine Atherosclerosis$483,947
P01 · FY2010 · HL · contact PI
Postdoctoral Training in Arteriosclerosis Research$478,276
T32 · FY2010 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$473,356
R01 · FY2010 · HL · contact PI
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$402,500
R01 · FY2010 · HL · contact PI
Creating Glucose Responsive Cardiovascular Complications$390,624
U01 · FY2010 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$476,304
R37 · FY2009 · HL · contact PI
Postdoctoral Training in Arteriosclerosis Research$474,440
T32 · FY2009 · HL · contact PI
Hyperglycemia, Aldose Reductase and Murine Atherosclerosis$470,101
P01 · FY2009 · HL · contact PI
Mechanisms of Fatty Acid Uptake By Cardiac Muscle$400,750
R01 · FY2009 · HL · contact PI
Creating Glucose Responsive Cardiovascular Complications$398,596
U01 · FY2009 · HL · contact PI
Postdoctoral Training in Arteriosclerosis Research$470,642
T32 · FY2008 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$453,733
R37 · FY2008 · HL · contact PI
Hyperglycemia, Aldose Reductase and Murine Atherosclerosis$450,019
P01 · FY2008 · HL · contact PI
Creating Glucose Responsive Cardiovascular Complications$398,596
U01 · FY2008 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$450,079
R37 · FY2007 · HL · contact PI
Hyperglycemia, Aldose Reductase and Murine Atherosclerosis$448,618
P01 · FY2007 · HL · contact PI
Creating Glucose Responsive Cardiovascular Complications$398,596
U01 · FY2007 · HL · contact PI
Mechanisms of fatty acid uptake by cardiac muscle$387,569
R01 · FY2007 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$448,620
R37 · FY2006 · HL · contact PI
Creating Glucose Responsive Cardiovascular Complications$425,750
U01 · FY2006 · HL · contact PI
Hyperglycemia, Aldose Reductase and Murine Atherosclerosis$402,500
P01 · FY2006 · HL · contact PI
Mechanisms of fatty acid uptake by cardiac muscle$399,144
R01 · FY2006 · HL · contact PI
Vascular Effects of Heparan Sulfate Proteoglycans$223,890
P50 · FY2006 · HL · contact PI
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$487,110
R37 · FY2005 · HL
Mechanisms of fatty acid uptake by cardiac muscle$408,750
R01 · FY2005 · HL
Hyperglycemia, Aldose Reducatse &Murine Atherosclerosis$305,900
R01 · FY2005 · DK
Vascular Effects of Heparan Sulfate Proteoglycans$218,846
P50 · FY2005 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$475,300
R37 · FY2004 · HL
Mechanisms of fatty acid uptake by cardiac muscle$408,750
R01 · FY2004 · HL
Vascular Effects of Heparan Sulfate Proteoglycans$213,948
P50 · FY2004 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$475,300
R37 · FY2003 · HL
Mechanisms of fatty acid uptake by cardiac muscle$408,750
R01 · FY2003 · HL
ATHEROGENICITY OF APOB CONTAINING LIPOPROTEINS$358,531
R01 · FY2003 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$9,760
R37 · FY2003 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$426,250
R37 · FY2002 · HL
ATHEROGENICITY OF APOB CONTAINING LIPOPROTEINS$350,496
R01 · FY2002 · HL
Vascular effects of heparan sulfate proteoglycans$0
P50 · FY2002 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$426,250
R37 · FY2001 · HL
ATHEROGENICITY OF APOB CONTAINING LIPOPROTEINS$342,695
R01 · FY2001 · HL
LIPOLYSIS, LIPOPROTEIN LIPASE AND ATHEROGENESIS$0
P50 · FY2001 · HL
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY$426,250
R37 · FY2000 · HL
ATHEROGENICITY OF APOB CONTAINING LIPOPROTEINS$335,122
R01 · FY2000 · HL
LIPOLYSIS, LIPOPROTEIN LIPASE AND ATHEROGENESIS$207,671
P50 · FY2000 · HL